Description

Description: Tirzepatide is a dual GIP and GLP‑1 receptor agonist peptide shown to improve glycaemic control and produce substantial body‑weight reduction in clinical studies. Used in pharmacology and metabolic research on diabetes, obesity, appetite regulation, and related endocrine/metabolic pathways.

Intended use: RESEARCH CHEMICAL — for in vitro testing and laboratory or regulated clinical research by qualified professionals only. Not for administration to humans or animals outside approved studies. Not a drug, food, or cosmetic; do not misbrand, misuse, or mislabel.